Skip to main content
Erschienen in: Supportive Care in Cancer 4/2019

18.08.2018 | Original Article

Relationship between skeletal muscle function, body composition, and weight loss in patients with advanced pancreatic and gastrointestinal cancers

verfasst von: P. Cresta Morgado, M. Daud, M. Carballido, G. Méndez, S. Iseas, V. Lobbe, G. De Simone, A. Navigante

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Muscle function and its correlation with body composition and weight loss have not been studied deeply in pancreas and gastrointestinal cancers. This research aims to determine the skeletal muscle function and its relationship with body compartments, significant weight loss, and performance status (ECOG) 0-2 in a population with advanced digestive cancers.

Methods

A cross-sectional study was designed to determine the relationship between muscular function, weight loss, and body composition. Patients with advanced digestive adenocarcinomas were evaluated. Muscle strength was examined by hand grip technique and body composition by bioimpedance analysis. Values of hemoglobin and albumin were measured in plasma.

Results

A sample of 81 patients was included. They had adenocarcinoma of stomach (n = 9), pancreas (n = 28), or colorectum (n = 44). With regard to skeletal muscle function, sub-maximal strength increased when percentage of weight loss decreased (p = 0.002) or when any of the following variables increased: skeletal muscle (p < 0.001), waist-hip ratio (p < 0.001), body surface area (p < 0.001), and body mass index (p = 0.001). According to multivariate analysis of these variables, only percentage of weight loss and skeletal muscle remained statistically significant. Endurance had no correlation with any of the variables. Higher weight loss was found in tumors of the upper tract (stomach and pancreas) in comparison with those of the lower tract (colorectal) (p = 0.005).

Conclusions

In advanced digestive cancer, sub-maximal strength correlated inversely with weight loss and directly with skeletal muscle such as in lung and head and neck cancers. On the other hand, endurance had no correlation with any of the variables considered.
Literatur
2.
Zurück zum Zitat Libutti SK, Saltz LB, Wollet C, Levine RA (2015) Cancer of the colon. In: De Vita H, Rosenberg (eds) Cancer: principles & practice of oncology, vol 57, 10th edn. Wolters Kluwer, pp 768–812 Libutti SK, Saltz LB, Wollet C, Levine RA (2015) Cancer of the colon. In: De Vita H, Rosenberg (eds) Cancer: principles & practice of oncology, vol 57, 10th edn. Wolters Kluwer, pp 768–812
4.
Zurück zum Zitat Matrisian L, Berlin J (2016) The past, present and future of pancreatic cancer clinical trials. Am Soc Clin Oncol Educ Book:e205-e215 Matrisian L, Berlin J (2016) The past, present and future of pancreatic cancer clinical trials. Am Soc Clin Oncol Educ Book:e205-e215
5.
Zurück zum Zitat Dry GK, Adjei A (2013) Understanding, recognizing, and managing toxicities of target anticancer therapies. CA Cancer J Clin 63:249–279CrossRef Dry GK, Adjei A (2013) Understanding, recognizing, and managing toxicities of target anticancer therapies. CA Cancer J Clin 63:249–279CrossRef
6.
Zurück zum Zitat Verger E, Salamero M, Comil C (1992) Can Karnofsky perfomance status be transformed to the Eastern Cooperative Oncology Group scoring scale and vice versa? Eur J Cancer 28A:1328–1330CrossRefPubMed Verger E, Salamero M, Comil C (1992) Can Karnofsky perfomance status be transformed to the Eastern Cooperative Oncology Group scoring scale and vice versa? Eur J Cancer 28A:1328–1330CrossRefPubMed
7.
Zurück zum Zitat Kilgour RD, Vigano A, Trutschingg B, Lucar E et al (2013) Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients. Support Care Cancer 21:3261–3270CrossRefPubMed Kilgour RD, Vigano A, Trutschingg B, Lucar E et al (2013) Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients. Support Care Cancer 21:3261–3270CrossRefPubMed
9.
Zurück zum Zitat Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69:491–497CrossRefPubMed Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69:491–497CrossRefPubMed
10.
Zurück zum Zitat Dy S, Lorenz K, Naeim A, Homayoon S et al (2008) Evidence-based recommendations for cancer fatigue, depression and dyspnea. J Clin Oncol 26:3886–3895CrossRefPubMed Dy S, Lorenz K, Naeim A, Homayoon S et al (2008) Evidence-based recommendations for cancer fatigue, depression and dyspnea. J Clin Oncol 26:3886–3895CrossRefPubMed
11.
Zurück zum Zitat Cerchietti L, Navigante A, Peluffo G, Diament M et al (2004) Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma. J Pain Symptom Manag 27:85–95CrossRef Cerchietti L, Navigante A, Peluffo G, Diament M et al (2004) Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma. J Pain Symptom Manag 27:85–95CrossRef
12.
Zurück zum Zitat Hauser K, Rybicki L, Walsh D (2010) What’s in a name? Word descriptors of cancer-related fatigue. Palliat Med 24(7):724–730CrossRefPubMed Hauser K, Rybicki L, Walsh D (2010) What’s in a name? Word descriptors of cancer-related fatigue. Palliat Med 24(7):724–730CrossRefPubMed
13.
Zurück zum Zitat Richardson A (1995) Fatigue in cancer patients: a review of the literature. Eur J Cancer Care 4:20–32CrossRef Richardson A (1995) Fatigue in cancer patients: a review of the literature. Eur J Cancer Care 4:20–32CrossRef
14.
Zurück zum Zitat Luthy C, Cedraschi C, Pugliesi A, Di Silvestro K et al (2011) Patients ‘views about causes and preferences for the management of cancer-related fatigue-a case for non congruent with physicians? Support Care Cancer 19:363–370CrossRefPubMed Luthy C, Cedraschi C, Pugliesi A, Di Silvestro K et al (2011) Patients ‘views about causes and preferences for the management of cancer-related fatigue-a case for non congruent with physicians? Support Care Cancer 19:363–370CrossRefPubMed
15.
Zurück zum Zitat Navigante A, Cresta Morgado P, Casbarien O, López Delgado N et al (2013) Relationship between weakness and phase angle in advanced cancer patients with fatigue. Support Care Cancer 21:1685–1690CrossRefPubMed Navigante A, Cresta Morgado P, Casbarien O, López Delgado N et al (2013) Relationship between weakness and phase angle in advanced cancer patients with fatigue. Support Care Cancer 21:1685–1690CrossRefPubMed
16.
Zurück zum Zitat Bautmans I, Gorus E, Njemini R, Mets T (2007) Handgrip performance in relation to self-perceived fatigue, physical functioning and circulating IL-6 in elderly persons without inflammation. BMC Geriatr 7:5CrossRefPubMedPubMedCentral Bautmans I, Gorus E, Njemini R, Mets T (2007) Handgrip performance in relation to self-perceived fatigue, physical functioning and circulating IL-6 in elderly persons without inflammation. BMC Geriatr 7:5CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE (2012) Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. BJC 107:931–936CrossRefPubMed Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE (2012) Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. BJC 107:931–936CrossRefPubMed
24.
Zurück zum Zitat Lieffers JR, Moutzakis M, Hall K, Mc Cargar L et al (2009) A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands. Am J Clin Nutr 89:1173–1179CrossRefPubMedPubMedCentral Lieffers JR, Moutzakis M, Hall K, Mc Cargar L et al (2009) A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands. Am J Clin Nutr 89:1173–1179CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Buchler M et al (2008) Cachexia worsen prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 12:1193–1201CrossRefPubMed Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Buchler M et al (2008) Cachexia worsen prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 12:1193–1201CrossRefPubMed
27.
Zurück zum Zitat Fogelman DR, Morris J, Xiao L, Hassan M, Vadhan S, Overman M, Javle S, Shroff R, Varadhachary G, Wolff R, Vence L, Maitra A, Cleeland C, Wang XS (2017) A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients. Support Care Cancer 25(6):1809–1817CrossRefPubMed Fogelman DR, Morris J, Xiao L, Hassan M, Vadhan S, Overman M, Javle S, Shroff R, Varadhachary G, Wolff R, Vence L, Maitra A, Cleeland C, Wang XS (2017) A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients. Support Care Cancer 25(6):1809–1817CrossRefPubMed
28.
Zurück zum Zitat Fisher D, Tish KM, Durivage H, Beaulieu N (2003) The cancer chemotherapy handbook. Mosby 11:486–497 Fisher D, Tish KM, Durivage H, Beaulieu N (2003) The cancer chemotherapy handbook. Mosby 11:486–497
29.
Zurück zum Zitat Blanchard E, Hesketh P (2015) Nausea and vomiting. In: De Vita H, Rosenberg’s (eds) Cancer: principles & practice of oncology, vol 135, 10th edn. Lippincott Williams & Wilkins, pp 1976–1983 Blanchard E, Hesketh P (2015) Nausea and vomiting. In: De Vita H, Rosenberg’s (eds) Cancer: principles & practice of oncology, vol 135, 10th edn. Lippincott Williams & Wilkins, pp 1976–1983
30.
Zurück zum Zitat Tilignac T, Temparis S, Combaret L, Taillandier D, Pouch MN, Cervek M, Cardenas DM, le Bricon T, Debiton E, Samuels SE, Madelmont JC, Attaix D (2002) Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis. Cancer Res 62:2771–2777PubMed Tilignac T, Temparis S, Combaret L, Taillandier D, Pouch MN, Cervek M, Cardenas DM, le Bricon T, Debiton E, Samuels SE, Madelmont JC, Attaix D (2002) Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis. Cancer Res 62:2771–2777PubMed
Metadaten
Titel
Relationship between skeletal muscle function, body composition, and weight loss in patients with advanced pancreatic and gastrointestinal cancers
verfasst von
P. Cresta Morgado
M. Daud
M. Carballido
G. Méndez
S. Iseas
V. Lobbe
G. De Simone
A. Navigante
Publikationsdatum
18.08.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4421-9

Weitere Artikel der Ausgabe 4/2019

Supportive Care in Cancer 4/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.